A Botox and Dysport Competitor: The FDA approved Xeomin for the treatment of frown lines.

Merz Aesthetics announced that the FDA has approved incobotulinum toxin A (Xeomin) for the temporary improvement in the appearance of frown lines. This product was approved by the FDA in July of 2010 for the treatment of cervical dystonia and blepharospasm, but has recently been approved for cosmetic use in the U.S.A.  This product has been used in 14 other counties under the brand name Bocouture for the treatment of frown lines.

With this recent FDA approval, you will be hearing more about Xeomin in the news and media. In the near future, we will see how it compares to Botox and Dysport in respect to:

  • the time it takes to see improvement
  • how long it lasts
  • cost

 

Advertisements

We want to know what you think. Leave a Reply.

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s